Literature DB >> 11925379

A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development.

Zhi-Bin Tong1, Carolyn A Bondy, Jian Zhou, Lawrence M Nelson.   

Abstract

BACKGROUND: Mater is a maternal effect gene required for early embryonic development in mice, and its protein serves as an autoantigen in a mouse model of autoimmune premature ovarian failure.
METHODS: Human MATER cDNA was cloned by PCR techniques. The mRNA and protein were determined using hybridization and immunodetection respectively. The cDNA and protein sequences were analysed using bioinformatics software.
RESULTS: Human MATER gene spans a approximately 63 kbp DNA at chromosome 19 and is composed of 15 exons and 14 introns. Expression of its mRNA (approximately 4.2 kb) is restricted to the oocytes. Human MATER cDNA (3885 nt) shows an open reading frame (3600 nt) encoding a polypeptide chain composed of 1200 residues with a predicted molecular mass of 134 236 Da. MATER protein (approximately 134 kDa) was detected in human oocytes. The human and mouse cDNA share 67% homology while their deduced polypeptide chains have 53% identity of amino acids. Also, their protein structures have a number of similar features.
CONCLUSIONS: The human MATER and mouse Mater genes and proteins are conserved. Characterization of the human MATER and its protein provides a basis for investigating their clinical implications in autoimmune premature ovarian failure and infertility in women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11925379     DOI: 10.1093/humrep/17.4.903

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

Review 1.  Mechanisms and models of immune tolerance breakdown in the ovary.

Authors:  Mickie H Cheng; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

Review 2.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

Review 3.  Portrait of an oocyte: our obscure origin.

Authors:  Roger Gosden; Bora Lee
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

4.  Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of mater.

Authors:  Noriyuki Otsuka; Zhi-Bin Tong; Konstantina Vanevski; Wei Tu; Mickie H Cheng; Lawrence M Nelson
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

5.  One world, one woman: a transformational leader's approach to primary ovarian insufficiency.

Authors:  Lawrence M Nelson
Journal:  Menopause       Date:  2011-05       Impact factor: 2.953

6.  The effects of vitrification on gene expression in mature mouse oocytes by nested quantitative PCR.

Authors:  Afrooz Habibi; Naser Farrokhi; Fernando Moreira da Silva; Bruno F Bettencourt; Jácome Bruges-Armas; Fardin Amidi; Ahmad Hosseini
Journal:  J Assist Reprod Genet       Date:  2010-08-17       Impact factor: 3.412

7.  Impact of gonadotropin supplementation on the expression of germ cell marker genes (MATER, ZAR1, GDF9, and BMP15) during in vitro maturation of buffalo (Bubalus bubalis) oocyte.

Authors:  Amar Nath; Veena Sharma; Pawan K Dubey; M D Pratheesh; Nitin E Gade; G Saikumar; G Taru Sharma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-12-14       Impact factor: 2.416

Review 8.  Oocyte-specific genes: role in fertility and infertility.

Authors:  B Meczekalski
Journal:  J Endocrinol Invest       Date:  2009-05       Impact factor: 4.256

9.  Differing molecular response of young and advanced maternal age human oocytes to IVM.

Authors:  J M Reyes; E Silva; J L Chitwood; W B Schoolcraft; R L Krisher; P J Ross
Journal:  Hum Reprod       Date:  2017-11-01       Impact factor: 6.918

10.  Evolution and functional divergence of NLRP genes in mammalian reproductive systems.

Authors:  Xin Tian; Géraldine Pascal; Philippe Monget
Journal:  BMC Evol Biol       Date:  2009-08-14       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.